Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers | |
Li, Xiaojiao; Liu, Ca; Zhu, Xiaoxue; Wei, Haijing; Zhang, Hong; Chen, Hong; Chen, Guiling; Yang, Deming; Sun, Hongbin; Shen, Zhenwei | |
刊名 | FRONTIERS IN PHARMACOLOGY |
2018 | |
卷号 | 9 |
关键词 | vicagrel pharmacokinetics pharmacodynamics safety clopidogrel |
ISSN号 | 1663-9812 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3537136 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Li, Xiaojiao,Liu, Ca,Zhu, Xiaoxue,et al. Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers[J]. FRONTIERS IN PHARMACOLOGY,2018,9. |
APA | Li, Xiaojiao.,Liu, Ca.,Zhu, Xiaoxue.,Wei, Haijing.,Zhang, Hong.,...&Ding, Yanhua.(2018).Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers.FRONTIERS IN PHARMACOLOGY,9. |
MLA | Li, Xiaojiao,et al."Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers".FRONTIERS IN PHARMACOLOGY 9(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论